Oscar Health, Inc. (NYSE:OSCR) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET

Company Participants

Cornelia Miller - VP, IR

Mark Bertolini - CEO & Director

Siddhartha Sankaran - Interim CFO & Director

Conference Call Participants

Stephen Baxter - Wells Fargo Securities

Jonathan Yong - Crédit Suisse

Michael Ha - Morgan Stanley

Gary Taylor - TD Cowen

Joshua Raskin - Nephron Research

Nathan Rich - Goldman Sachs Group

Kevin Fischbeck - Bank of America Merrill Lynch

Operator

Good afternoon. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's 2023 Second Quarter Earnings Conference Call. [Operator Instructions].

Thank you. I will now turn the conference over to Cornelia Miller, Vice President of Corporate Development and Investor Relations.

Cornelia Miller

Thank you, and good evening, everyone. Thank you for joining us for our second quarter 2023 earnings call, where we'll discuss our strong first half results, disciplined execution and path to profitability. Mark Bertolini, Oscar's Chief Executive Officer; and Sid Sankaran, Oscar's Chief Financial Officer, will host this evening's call. This call can be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our Investor Relations website at ir.hioscar.com.

Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our quarterly report on Form 10-Q for the quarterly period ended March 31, 2023, filed with the SEC and other filings with the SEC, including our quarterly report on Form 10-Q for the quarterly period ended June 30, 2023, to be filed with the SEC.

Such forward-looking statements are based on current expectations as of today. Oscar anticipates that subsequent events and developments may cause estimates to change. While the company may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so.

The call will also refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in the second quarter 2023 press release, which is available on the company's Investor Relations website at ir.hioscar.com.